MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
207 hedge funds and large institutions have $2.38B invested in Mirati Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 82 increasing their positions, 67 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
207
Holders Change
-14
Holders Change %
-6.33%
% of All Funds
3.26%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
27
Increased
82
Reduced
67
Closed
41
Calls
$33.6M
Puts
$11.3M
Net Calls
+$22.3M
Net Calls Change
+$16.2M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$30M |
| 2 |
Morgan Stanley
New York
|
+$28.7M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$25M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$20M |
| 5 |
AG
Artal Group
Luxembourg
|
+$18.7M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$30.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24M |
| 3 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$18.6M |
| 4 |
CC
Casdin Capital
New York
|
-$17.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$11.9M |
